This paperwork
is approved on an emergency basis for 6 months. No emergency
extensions will be granted for this collection. Prior to the
expiration date (11/30/2006), FDA must submit to OMB a request for
an extension including a summary of the public comments received
and how the agency will address substantive issues raised by
commenters. We will also expect an update on the progress of the
final rule when we review the PRA extension request.
Inventory as of this Action
Requested
Previously Approved
11/30/2006
11/30/2006
450
0
0
900
0
0
0
0
0
The interim final rule would amend
FDA#s informed consent regulation to provide an exception to the
general requirement to obtain informed consent from the subject of
an investigation involving and unapproved or not cleared in vitro
diagnostic device intended to identify a chemical, biological,
radiological, or nuclear agent.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.